Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial.

Schisterman EF, Sjaarda LA, Clemons T, Carrell DT, Perkins NJ, Johnstone E, Lamb D, Chaney K, Van Voorhis BJ, Ryan G, Summers K, Hotaling J, Robins J, Mills JL, Mendola P, Chen Z, DeVilbiss EA, Peterson CM, Mumford SL.

JAMA. 2020 Jan 7;323(1):35-48. doi: 10.1001/jama.2019.18714.

PMID:
31910279
2.

Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40.

Christakis PG, Agrón E, Klein ML, Clemons TE, Campbell JP, Ferris FL, Chew EY, Keenan TD; Age-Related Eye Diseases Study Research Group.

Ophthalmology. 2019 Nov 26. pii: S0161-6420(19)32297-3. doi: 10.1016/j.ophtha.2019.11.016. [Epub ahead of print]

PMID:
31899035
3.

A Randomized Trial to Evaluate the Effects of Folic Acid and Zinc Supplementation on Male Fertility and Live Birth: Design and Baseline Characteristics.

Schisterman EF, Clemons T, Peterson CM, Johnstone E, Hammoud AO, Lamb D, Carrell DT, Perkins NJ, Sjaarda LA, Van Voorhis BJ, Ryan G, Summers K, Campbell B, Robins J, Chaney K, Mills JL, Mendola P, Chen Z, DeVilbiss EA, Mumford SL.

Am J Epidemiol. 2019 Nov 12. pii: kwz217. doi: 10.1093/aje/kwz217. [Epub ahead of print]

PMID:
31712803
4.

Novel Hydrophilic Copolymer-Based Nanoparticle Enhances the Therapeutic Efficiency of Doxorubicin in Cultured MCF-7 Cells.

Naidu PSR, Norret M, Dunlop SA, Fitzgerald M, Clemons TD, Iyer KS.

ACS Omega. 2019 Oct 11;4(17):17083-17089. doi: 10.1021/acsomega.8b02894. eCollection 2019 Oct 22.

5.

Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.

Domalpally A, Agrón E, Pak JW, Keenan TD, Ferris FL 3rd, Clemons TE, Chew EY.

Ophthalmology. 2019 Dec;126(12):1659-1666. doi: 10.1016/j.ophtha.2019.07.022. Epub 2019 Jul 29.

PMID:
31558345
6.

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.

Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmol Retina. 2020 Jan;4(1):3-12. doi: 10.1016/j.oret.2019.06.001. Epub 2019 Jun 11.

PMID:
31395505
7.

The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.

Keenan TD, Wiley HE, Agrón E, Aronow ME, Christen WG, Clemons TE, Chew EY; Age-Related Eye Disease Study and Age-Related Eye Disease Study 2 Research Groups.

Ophthalmology. 2019 Dec;126(12):1647-1656. doi: 10.1016/j.ophtha.2019.06.023. Epub 2019 Jun 26.

PMID:
31358390
8.

No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.

van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2019 Nov;126(11):1541-1548. doi: 10.1016/j.ophtha.2019.06.004. Epub 2019 Jun 12.

PMID:
31358387
9.

Precursors and Development of Geographic Atrophy with Autofluorescence Imaging: Age-Related Eye Disease Study 2 Report Number 18.

Holmen IC, Aul B, Pak JW, Trane RM, Blodi B, Klein M, Clemons T, Chew E, Domalpally A; Age-Related Eye Disease Study 2 Research Group.

Ophthalmol Retina. 2019 Sep;3(9):724-733. doi: 10.1016/j.oret.2019.04.011. Epub 2019 Apr 12.

PMID:
31153849
10.

Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis.

Mansukhani NA, Peters EB, So MM, Albaghdadi MS, Wang Z, Karver MR, Clemons TD, Laux JP, Tsihlis ND, Stupp SI, Kibbe MR.

Macromol Biosci. 2019 Jun;19(6):e1900066. doi: 10.1002/mabi.201900066. Epub 2019 May 8.

PMID:
31066494
11.

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Sorolla A, Wang E, Clemons TD, Evans CW, Plani-Lam JH, Golden E, Dessauvagie B, Redfern AD, Swaminathan-Iyer K, Blancafort P.

Nanomedicine. 2019 Aug;20:102003. doi: 10.1016/j.nano.2019.04.006. Epub 2019 May 2.

12.

Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.

Domalpally A, Clemons TE, Bressler SB, Danis RP, Elman M, Kim JE, Brown D, Chew EY.

Ophthalmol Retina. 2019 Apr;3(4):326-335. doi: 10.1016/j.oret.2019.01.004. Epub 2019 Jan 11.

PMID:
31014685
13.

Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TF, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB; MacTel Study Group.

Acta Ophthalmol. 2019 Nov;97(7):e998-e1005. doi: 10.1111/aos.14110. Epub 2019 Apr 9.

PMID:
30968592
14.

Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.

Tisdale AK, Agrón E, Sunshine SB, Clemons TE, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2019 May 1;137(5):543-550. doi: 10.1001/jamaophthalmol.2019.0292.

PMID:
30896764
15.

Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.

Findling RL, McNamara NK, Pavuluri M, Frazier JA, Rynn M, Scheffer R, Kafantaris V, Robb A, DelBello M, Kowatch RA, Rowles BM, Lingler J, Zhao J, Clemons T, Martz K, Anand R, Taylor-Zapata P.

J Am Acad Child Adolesc Psychiatry. 2019 Feb;58(2):287-296.e4. doi: 10.1016/j.jaac.2018.07.901. Epub 2018 Nov 26.

PMID:
30738555
16.

Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15.

Domalpally A, Danis RP, Trane R, Blodi BA, Clemons TE, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

Ophthalmol Retina. 2018 Oct;2(10):1021-1027. doi: 10.1016/j.oret.2018.04.009. Epub 2018 Jun 2.

17.

Distinction Between Active and Passive Targeting of Nanoparticles Dictate Their Overall Therapeutic Efficacy.

Clemons TD, Singh R, Sorolla A, Chaudhari N, Hubbard A, Iyer KS.

Langmuir. 2018 Dec 18;34(50):15343-15349. doi: 10.1021/acs.langmuir.8b02946. Epub 2018 Nov 27.

PMID:
30441895
18.

Intracellular speciation of gold nanorods alters the conformational dynamics of genomic DNA.

Ho D, Kretzmann JA, Norret M, Toshniwal P, Veder JP, Jiang H, Guagliardo P, Munshi AM, Chawla R, Evans CW, Clemons TD, Nguyen M, Kretzmann AL, Blythe AJ, Saunders M, Archer M, Fitzgerald M, Keelan JA, Bond CS, Kilburn MR, Hurley LH, Smith NM, Iyer KS.

Nat Nanotechnol. 2018 Dec;13(12):1148-1153. doi: 10.1038/s41565-018-0272-2. Epub 2018 Oct 8.

PMID:
30297819
19.

Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.

Chew EY, Clemons TE, Jaffe GJ, Johnson CA, Farsiu S, Lad EM, Guymer R, Rosenfeld P, Hubschman JP, Constable I, Wiley H, Singerman LJ, Gillies M, Comer G, Blodi B, Eliott D, Yan J, Bird A, Friedlander M; Macular Telangiectasia Type 2-Phase 2 CNTF Research Group.

Ophthalmology. 2019 Apr;126(4):540-549. doi: 10.1016/j.ophtha.2018.09.041. Epub 2018 Oct 4.

PMID:
30292541
20.

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2019 Feb;126(2):261-273. doi: 10.1016/j.ophtha.2018.08.017. Epub 2018 Aug 22.

PMID:
30142373
21.

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group.

Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27.

22.

No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study.

Lee MG, Marshall NS, Clemons TE, Hunter ML, James AL, Grunstein RR, Nguyen V, Campain A, Gillies MC.

Clin Exp Ophthalmol. 2019 Jan;47(1):63-68. doi: 10.1111/ceo.13363. Epub 2018 Aug 19.

PMID:
30047178
23.

Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.

Gensler G, Clemons TE, Domalpally A, Danis RP, Blodi B, Wells J 3rd, Rauser M, Hoskins J, Hubbard GB, Elman MJ, Fish GE, Brucker A, Margherio A, Chew EY.

Ophthalmol Retina. 2018 May;2(5):441-450. doi: 10.1016/j.oret.2017.08.015.

24.

Genome-wide analysis of disease progression in age-related macular degeneration.

Yan Q, Ding Y, Liu Y, Sun T, Fritsche LG, Clemons T, Ratnapriya R, Klein ML, Cook RJ, Liu Y, Fan R, Wei L, Abecasis GR, Swaroop A, Chew EY; AREDS2 Research Group, Weeks DE, Chen W.

Hum Mol Genet. 2018 Mar 1;27(5):929-940. doi: 10.1093/hmg/ddy002.

25.

Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.

Age-Related Eye Disease Study 2 Research Group, Papudesu C, Clemons TE, Agrón E, Chew EY.

Ophthalmology. 2018 Apr;125(4):512-521. doi: 10.1016/j.ophtha.2017.10.028. Epub 2017 Nov 16.

26.

A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.

van Asten F, Simmons M, Singhal A, Keenan TD, Ratnapriya R, Agrón E, Clemons TE, Swaroop A, Lu Z, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2018 Apr;125(4):559-568. doi: 10.1016/j.ophtha.2017.09.023. Epub 2017 Oct 31.

27.

CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, Bird AC, Peto T; MacTel Study Group.

Retina. 2018 Jan;38 Suppl 1:S43-S50. doi: 10.1097/IAE.0000000000001842.

28.

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.

Mukherjee D, Lad EM, Vann RR, Jaffe SJ, Clemons TE, Friedlander M, Chew EY, Jaffe GJ, Farsiu S; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO291-BIO299. doi: 10.1167/iovs.17-21834.

29.

Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.

Wolf-Schnurrbusch UEK, Leung I, Sallo FB, Clemons TE, Chew EY, Bird AC, Peto T; MacTel Study Group.

Ophthalmic Res. 2018;60(1):38-42. doi: 10.1159/000479932. Epub 2017 Sep 13.

30.

Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.

Sleiman K, Veerappan M, Winter KP, McCall MN, Yiu G, Farsiu S, Chew EY, Clemons T, Toth CA; Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group.

Ophthalmology. 2017 Dec;124(12):1764-1777. doi: 10.1016/j.ophtha.2017.06.032. Epub 2017 Aug 26.

31.

SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2.

Müller S, Allam JP, Bunzek CG, Clemons TE, Holz FG, Charbel Issa P.

Retina. 2018 Jan;38 Suppl 1:S61-S66. doi: 10.1097/IAE.0000000000001789.

PMID:
28837534
32.

Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.

Lee AY, Butt T, Chew E, Agron E, Clemons TE, Egan CA, Lee CS, Tufail A; UK EMR AMD Research Group.

Br J Ophthalmol. 2018 Apr;102(4):465-472. doi: 10.1136/bjophthalmol-2017-310939. Epub 2017 Aug 23.

33.

ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, Pauleikhoff D, Chew EY, Egan C, Peto T, Bird AC; MacTel Study Group.

Retina. 2018 Jan;38 Suppl 1:S79-S88. doi: 10.1097/IAE.0000000000001728.

34.

CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Sallo FB, Leung I, Clemons TE, Peto T, Chew EY, Pauleikhoff D, Bird AC; MacTel CNTF Research Group.

Retina. 2018 Jan;38 Suppl 1:S27-S32. doi: 10.1097/IAE.0000000000001706.

35.

LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.

Heeren TFC, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, Pauleikhoff D, Charbel Issa P, Holz FG, Peto T.

Retina. 2018 Jan;38 Suppl 1:S20-S26. doi: 10.1097/IAE.0000000000001715.

PMID:
28541959
36.

CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.

Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, Bird AC.

Retina. 2018 Jan;38 Suppl 1:S8-S13. doi: 10.1097/IAE.0000000000001697.

PMID:
28505012
37.

Sand training: Exercise-induced muscle damage and inflammatory responses to matched-intensity exercise.

Brown H, Dawson B, Binnie MJ, Pinnington H, Sim M, Clemons TD, Peeling P.

Eur J Sport Sci. 2017 Jul;17(6):741-747. doi: 10.1080/17461391.2017.1304998. Epub 2017 Apr 12.

38.

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.

Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D.

JAMA Ophthalmol. 2017 May 1;135(5):452-459. doi: 10.1001/jamaophthalmol.2017.0255.

39.

Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.

Ding Y, Liu Y, Yan Q, Fritsche LG, Cook RJ, Clemons T, Ratnapriya R, Klein ML, Abecasis GR, Swaroop A, Chew EY, Weeks DE, Chen W; AREDS2 Research Group.

Genetics. 2017 May;206(1):119-133. doi: 10.1534/genetics.116.196998. Epub 2017 Mar 24.

40.

Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.

Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2), Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, Friberg TR, Chew EY.

Ophthalmology. 2017 Apr;124(4):479-487. doi: 10.1016/j.ophtha.2016.12.004. Epub 2017 Jan 12.

PMID:
28089680
41.

Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.

Domalpally A, Danis R, Agrón E, Blodi B, Clemons T, Chew E; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2016 Nov;123(11):2401-2407. doi: 10.1016/j.ophtha.2016.06.025. Epub 2016 Jul 19.

42.

Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.

Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group.

JAMA Ophthalmol. 2016 Sep 1;134(9):1041-7. doi: 10.1001/jamaophthalmol.2016.2383.

PMID:
27442263
43.

EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3.

Chew EY, Clemons TE, Harrington M, Bressler SB, Elman MJ, Kim JE, Garfinkel R, Heier JS, Brucker A, Boyer D; AREDS2-HOME Study Research Group.

Retina. 2016 Aug;36(8):1542-7. doi: 10.1097/IAE.0000000000000940.

44.

The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group, Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.

45.

Hexokinase: A Glycolytic Enzyme with an Inflammatory Ischemia and Reperfusion Connection.

Clemons TA, Toledo-Pereyra LH.

J Invest Surg. 2015;28(6):301-2. doi: 10.3109/08941939.2015.1121674. No abstract available.

PMID:
26654433
46.

A comparison of haemolytic responses in fore-foot and rear-foot distance runners.

Caulfield S, McDonald KA, Dawson B, Stearne SM, Green BA, Rubenson J, Clemons TD, Peeling P.

J Sports Sci. 2016 Aug;34(15):1485-90. doi: 10.1080/02640414.2015.1119300. Epub 2015 Nov 30.

47.

Enhancing the efficacy of cation-independent mannose 6-phosphate receptor inhibitors by intracellular delivery.

Agarwal V, Toshniwal P, Smith NE, Smith NM, Li B, Clemons TD, Byrne LT, Kakulas F, Wood FM, Fear M, Corry B, Swaminathan Iyer K.

Chem Commun (Camb). 2016 Jan 7;52(2):327-30. doi: 10.1039/c5cc06826f. Epub 2015 Oct 30.

PMID:
26514404
48.

Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study.

Findling RL, Robb A, McNamara NK, Pavuluri MN, Kafantaris V, Scheffer R, Frazier JA, Rynn M, DelBello M, Kowatch RA, Rowles BM, Lingler J, Martz K, Anand R, Clemons TE, Taylor-Zapata P.

Pediatrics. 2015 Nov;136(5):885-94. doi: 10.1542/peds.2015-0743. Epub 2015 Oct 12.

49.

The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2015 Dec;122(12):2490-6. doi: 10.1016/j.ophtha.2015.08.028. Epub 2015 Oct 4.

50.

Reply: To PMID 25456150.

Chew EY, Klein ML, Clemons TE, Agrón E, Abecasis GR.

Ophthalmology. 2015 Oct;122(10):e63. doi: 10.1016/j.ophtha.2015.03.029. No abstract available.

PMID:
26398062

Supplemental Content

Loading ...
Support Center